{"title":"Follow-up Outcomes of Patients Presenting With Ovarian Masses in Childhood: A 15-Year Single-center Experience.","authors":"Aytül Temuroğlu, Betül B Sevinir","doi":"10.1097/MPH.0000000000003043","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Ovarian tumors in childhood are rare. This study aimed to examine the clinical characteristics of pediatric patients presenting with ovarian masses.</p><p><strong>Materials and methods: </strong>A retrospective review of patient data was conducted for patients who presented to our clinic with an ovarian mass between 2009 and 2024.</p><p><strong>Results: </strong>The study included 85 patients treated for ovarian masses in our clinic. The mean age of the patients was 12.2±4.6 (range: 0 to 18) years. The mean size of malignant tumors was 12.1±7.2 cm, and that of benign tumors was 10.74±7 cm ( P =0.43). On the basis of operation type, the mean tumor size in patients who underwent oophorectomy was 12.66±7.2 cm, compared with 8.59±6.15 cm in those with a cystectomy ( P =0.017). Histopathologic examination reported 54.1% (n=46) of tumors as benign, 32.9% (n=31) as malignant, 5.9% (n=5) as borderline, and 3.5% (n=3) as non-neoplastic lesions. Germ cell tumors were the most common, constituting 67.1% (n=57) of cases, followed by epithelial tumors at 22.4% (n=19). Synchronous bilateral ovarian tumors were identified in 4 cases. Chemotherapy was administered to 32.9% (n=28) of the patients. The mean follow-up period was 45 (1 to 204) months. A recurrence was observed in 1 patient, followed up with a diagnosis of immature teratoma. Two patients (2.4%) died, 1 due to acute renal failure and the other due to sepsis.</p><p><strong>Conclusions: </strong>Ovarian tumors in childhood are rare and have high treatment success rates. Further research is needed to improve ovary-preserving surgical approaches and mitigate the side effects of chemotherapy.</p>","PeriodicalId":16693,"journal":{"name":"Journal of Pediatric Hematology/Oncology","volume":" ","pages":"e187-e191"},"PeriodicalIF":0.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Hematology/Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MPH.0000000000003043","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Ovarian tumors in childhood are rare. This study aimed to examine the clinical characteristics of pediatric patients presenting with ovarian masses.
Materials and methods: A retrospective review of patient data was conducted for patients who presented to our clinic with an ovarian mass between 2009 and 2024.
Results: The study included 85 patients treated for ovarian masses in our clinic. The mean age of the patients was 12.2±4.6 (range: 0 to 18) years. The mean size of malignant tumors was 12.1±7.2 cm, and that of benign tumors was 10.74±7 cm ( P =0.43). On the basis of operation type, the mean tumor size in patients who underwent oophorectomy was 12.66±7.2 cm, compared with 8.59±6.15 cm in those with a cystectomy ( P =0.017). Histopathologic examination reported 54.1% (n=46) of tumors as benign, 32.9% (n=31) as malignant, 5.9% (n=5) as borderline, and 3.5% (n=3) as non-neoplastic lesions. Germ cell tumors were the most common, constituting 67.1% (n=57) of cases, followed by epithelial tumors at 22.4% (n=19). Synchronous bilateral ovarian tumors were identified in 4 cases. Chemotherapy was administered to 32.9% (n=28) of the patients. The mean follow-up period was 45 (1 to 204) months. A recurrence was observed in 1 patient, followed up with a diagnosis of immature teratoma. Two patients (2.4%) died, 1 due to acute renal failure and the other due to sepsis.
Conclusions: Ovarian tumors in childhood are rare and have high treatment success rates. Further research is needed to improve ovary-preserving surgical approaches and mitigate the side effects of chemotherapy.
期刊介绍:
Journal of Pediatric Hematology/Oncology (JPHO) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. The journal publishes original research, commentaries, historical insights, and clinical and laboratory observations.